Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial de Zeeuw, D., Arnott, C., Li, J., Cannon, C. P., Neuen, B. L., Heerspink, H. L., Neal, B., Charytan, D. M., Bakris, G., Chang, T., Rosenthal, N., Zinman, B., Perkovic, V., Jardine, M. J., Mahaffey, K. W. SPRINGER. 2020: S61–S62
View details for Web of Science ID 000565776600123